Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.

Bilavsky E, Temkin E, Lerman Y, Rabinovich A, Salomon J, Lawrence C, Rossini A, Salvia A, Samso JV, Fierro J, Paul M, Hart J, Gniadkowski M, Hochman M, Kazma M, Klein A, Adler A, Schwaber MJ, Carmeli Y; MOSAR WP5 study team..

Clin Microbiol Infect. 2014 Nov;20(11):O804-10. doi: 10.1111/1469-0691.12633. Epub 2014 May 15.

2.
3.

Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.

Lübbert C, Straube L, Stein C, Makarewicz O, Schubert S, Mössner J, Pletz MW, Rodloff AC.

Int J Med Microbiol. 2015 Jan;305(1):148-56. doi: 10.1016/j.ijmm.2014.12.001. Epub 2014 Dec 9.

PMID:
25547265
4.

A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.

Adler A, Baraniak A, Izdebski R, Fiett J, Salvia A, Samso JV, Lawrence C, Solomon J, Paul M, Lerman Y, Schwartzberg Y, Mordechai E, Rossini A, Fierro J, Lammens C, Malhotra-Kumar S, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M, Carmeli Y; MOSAR team..

Clin Microbiol Infect. 2014 Aug;20(8):O516-23. doi: 10.1111/1469-0691.12560. Epub 2014 Mar 5.

5.

High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon.

Schaumburg F, Alabi A, Kokou C, Grobusch MP, Köck R, Kaba H, Becker K, Adegnika AA, Kremsner PG, Peters G, Mellmann A.

J Antimicrob Chemother. 2013 Sep;68(9):2140-3. doi: 10.1093/jac/dkt164. Epub 2013 May 3.

PMID:
23645586
6.

Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

Razazi K, Derde LP, Verachten M, Legrand P, Lesprit P, Brun-Buisson C.

Intensive Care Med. 2012 Nov;38(11):1769-78. doi: 10.1007/s00134-012-2675-0. Epub 2012 Aug 15.

PMID:
22893223
7.

Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C; BacterCom Study Group..

Int J Antimicrob Agents. 2017 Jan;49(1):67-73. doi: 10.1016/j.ijantimicag.2016.09.032. Epub 2016 Nov 16.

PMID:
27890442
8.

Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.

Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, Noskin GA, Zembower T.

Clin Infect Dis. 2007 Oct 1;45(7):846-52. Epub 2007 Aug 20.

PMID:
17806048
9.

Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities.

Arnoldo L, Migliavacca R, Regattin L, Raglio A, Pagani L, Nucleo E, Spalla M, Vailati F, Agodi A, Mosca A, Zotti C, Tardivo S, Bianco I, Rulli A, Gualdi P, Panetta P, Pasini C, Pedroni M, Brusaferro S.

BMC Infect Dis. 2013 Mar 6;13:124. doi: 10.1186/1471-2334-13-124.

10.

Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.

Ostholm-Balkhed A, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hällgren A; Travel Study Group of Southeast Sweden..

J Antimicrob Chemother. 2013 Sep;68(9):2144-53. doi: 10.1093/jac/dkt167. Epub 2013 May 14.

PMID:
23674762
11.

Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors.

Papst L, Beović B, Seme K, Pirš M.

Infect Dis (Lond). 2015 Sep;47(9):618-24. doi: 10.3109/23744235.2015.1033003. Epub 2015 Apr 13.

PMID:
25865350
12.

Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study.

Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, Thijsen SF, Mascini EM, van Hees BC, Scharringa J, Fluit AC, Bonten MJ.

Clin Microbiol Infect. 2015 Feb;21(2):141-6. doi: 10.1016/j.cmi.2014.09.014. Epub 2014 Oct 29.

13.
14.

Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience.

Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, Poddar B, Mishra A, Gurjar M, Dhole TN.

J Med Microbiol. 2010 Aug;59(Pt 8):955-60. doi: 10.1099/jmm.0.018085-0. Epub 2010 Apr 22.

PMID:
20413621
15.

Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study.

Angelin M, Forsell J, Granlund M, Evengård B, Palmgren H, Johansson A.

Travel Med Infect Dis. 2015 May-Jun;13(3):223-9. doi: 10.1016/j.tmaid.2015.04.007. Epub 2015 May 5.

PMID:
25982453
16.

Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

Nakai H, Hagihara M, Kato H, Hirai J, Nishiyama N, Koizumi Y, Sakanashi D, Suematsu H, Yamagishi Y, Mikamo H.

J Infect Chemother. 2016 May;22(5):319-26. doi: 10.1016/j.jiac.2016.02.004. Epub 2016 Mar 8.

PMID:
26968486
17.

A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.

Adler A, Baraniak A, Izdebski R, Fiett J, Gniadkowski M, Hryniewicz W, Salvia A, Rossini A, Goossens H, Malhotra S, Lerman Y, Elenbogen M, Carmeli Y; MOSAR WP5 & WP2 study groups..

Clin Microbiol Infect. 2013 Feb;19(2):E51-8. doi: 10.1111/1469-0691.12072. Epub 2012 Dec 4.

18.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors.

Shitrit P, Reisfeld S, Paitan Y, Gottesman BS, Katzir M, Paul M, Chowers M.

J Hosp Infect. 2013 Nov;85(3):230-2. doi: 10.1016/j.jhin.2013.07.014. Epub 2013 Sep 8.

PMID:
24080081
19.

Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?

Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF; OUTCOMEREA Study Group..

J Antimicrob Chemother. 2016 Apr;71(4):1088-97. doi: 10.1093/jac/dkv423. Epub 2016 Jan 10.

PMID:
26755492
20.

A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y.

Clin Infect Dis. 2009 Sep 1;49(5):682-90. doi: 10.1086/604713.

PMID:
19622043

Supplemental Content

Support Center